The Capulana study: a prospective evaluation of cervical cancer screening using human papillomavirus testing in Mozambique.
Mila Pontremoli SalcedoCristina OliveiraViviane AndradeArlete A N MarianoDércia ChanguleRicardina RangeiroEliane C S MonteiroEllen BakerNatacha PhoolcharoenMelissa Lopez VaronJoseph P ThomasPhilip E CastleJose Humberto T G FregnaniKathleen M SchmelerCesaltina LorenzoniPublished in: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society (2020)
Cervical cancer screening with HPV testing, including appropriate follow-up and treatment, was feasible in our study cohort in Mozambique. Women living with human immunodeficiency virus appear to be at a significantly higher risk for HPV infection and the development of invasive cervical cancer than human immunodeficiency virus negative women.